While a security is undergoing reorganization, it will not be available for online trading. Such corporate actions can include name changes, symbol changes, mergers and forward or reverse splits.
We will post the new shares of GHLVD to your account once payment has been received from the depository or agent. We do not have an anticipated date of receiving the new shares at this time. Your patience is greatly appreciated.
Global Health Ventures Inc. Announces Name Change And Corporate Restructuring
Global Health Ventures Inc. announced the following corporate actions. On September 23, 2011, the Company completed a merger with its wholly owned subsidiary, Kedem Pharmaceuticals Inc., and formally assumed the subsidiary's name by filing Articles of Merger with the Nevada Secretary of State. On September 26, 2011, the Company completed a 1 for 20 reverse split of its common stock and effected a corresponding decrease in its authorized capital by filing of a Certificate of Change with the Nevada Secretary of State. As a result of the reverse split, the Company's authorized common stock decreased from 1,000,000,000 shares to 50,000,000, and its issued and outstanding common stock decreased from 196,333,192 shares to 9,816,660. In order for the name change and reverse split to be recognized on the OTC Bulletin Board, the Financial Industry Regulatory Authority (FINRA) was required to process the corporate actions. FINRA has now processed the name change and reverse split, both of which became effective in the market at the open of business on November 7, 2011. At that time, the Company's common stock became eligible for quotation on the OTC Bulletin Board under the name Kedem Pharmaceuticals Inc. and the trading symbol GHLVD.ob.